Please login to the form below

Not currently logged in
Email:
Password:

Arrow

This page shows the latest Arrow news and features for those working in and with pharma, biotech and healthcare.

RET rivals Loxo and Blueprint face off with early-stage data

RET rivals Loxo and Blueprint face off with early-stage data

The ARROW trial revealed that 90% of patients with RET-altered medullary and papillary thyroid cancers had reduction in tumour volume overall, with a 62% response rate in medullary patients treated

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • The doctor will see you now? The doctor will see you now?

    As said initially, long waiting is not a matter of money, number of staff or size of arrows between squares in an organisation's chart.

  • Healthcare industry apps Healthcare industry apps

    Dr Trombino. Dr Trombino's arrows contain a direct thrombin inhibitor: fire them at the yellow factors to prevent the formation of blood clots!

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Dr David Chiswell joins Kymab Dr David Chiswell joins Kymab

    He brings over 30 years of biotechnology expertise to the firm, having held senior management positions at a number of pharmaceutical companies, including Arakis, Arrow Therapeutics, Daniolabs and Sosei.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics